These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16409238)

  • 41. Subconjunctivally implanted micro-osmotic pumps for continuous ocular treatment in horses.
    Blair MJ; Gionfriddo JR; Polazzi LM; Sojka JE; Pfaff AM; Bingaman DP
    Am J Vet Res; 1999 Sep; 60(9):1102-5. PubMed ID: 10490079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autologous serum eyedrops in the treatment of aniridic keratopathy.
    López-García JS; Rivas L; García-Lozano I; Murube J
    Ophthalmology; 2008 Feb; 115(2):262-7. PubMed ID: 17675158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluorescein dye disappearance test in patients with different degrees of epiphora.
    Toprak AB; Erkin EF; Kayikçioğlu O; Seymenoğlu G; Güler C; Unlu HH
    Eur J Ophthalmol; 2002; 12(5):359-65. PubMed ID: 12474916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical ophthalmic atropine in horses, pharmacokinetics and effect on intestinal motility.
    Ström L; Dalin F; Domberg M; Stenlund C; Bondesson U; Hedeland M; Toutain PL; Ekstrand C
    BMC Vet Res; 2021 Apr; 17(1):149. PubMed ID: 33827566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of matrix metalloproteinase concentrations in precorneal tear film from dogs with Pseudomonas aeruginosa-associated keratitis.
    Wang L; Pan Q; Xue Q; Cui J; Qi C
    Am J Vet Res; 2008 Oct; 69(10):1341-5. PubMed ID: 18828693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative study of treatment of the dry eye syndrome due to disturbances of the tear film lipid layer with lipid-containing tear substitutes].
    Dausch D; Lee S; Dausch S; Kim JC; Schwert G; Michelson W
    Klin Monbl Augenheilkd; 2006 Dec; 223(12):974-83. PubMed ID: 17199193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo release from a drug delivery MEMS device.
    Li Y; Shawgo RS; Tyler B; Henderson PT; Vogel JS; Rosenberg A; Storm PB; Langer R; Brem H; Cima MJ
    J Control Release; 2004 Nov; 100(2):211-9. PubMed ID: 15544869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluorophotometric measurement of the precorneal residence time of topically applied hyaluronic acid.
    Mochizuki H; Yamada M; Hato S; Nishida T
    Br J Ophthalmol; 2008 Jan; 92(1):108-11. PubMed ID: 18156377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A clinical evaluation of Systane.
    Gifford P; Evans BJ; Morris J
    Cont Lens Anterior Eye; 2006 Mar; 29(1):31-40. PubMed ID: 16473547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of nasal conjunctivochalasis on tear functions and ocular surface findings.
    Wang Y; Dogru M; Matsumoto Y; Ward SK; Ayako I; Hu Y; Okada N; Ogawa Y; Shimazaki J; Tsubota K
    Am J Ophthalmol; 2007 Dec; 144(6):930-937. PubMed ID: 17916317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tear cytokine and ocular surface alterations following brief passive cigarette smoke exposure.
    Rummenie VT; Matsumoto Y; Dogru M; Wang Y; Hu Y; Ward SK; Igarashi A; Wakamatsu T; Ibrahim O; Goto E; Luyten G; Inoue H; Saito I; Shimazaki J; Tsubota K
    Cytokine; 2008 Aug; 43(2):200-8. PubMed ID: 18602273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Barriers to glaucoma drug delivery.
    Ghate D; Edelhauser HF
    J Glaucoma; 2008 Mar; 17(2):147-56. PubMed ID: 18344762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tear film osmolality and electrolyte composition in healthy horses.
    Best LJ; Hendrix DV; Ward DA
    Am J Vet Res; 2015 Dec; 76(12):1066-9. PubMed ID: 26618731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of tear film and contact lens osmolality on ocular comfort in contact lens wear.
    Stahl U; Willcox MD; Naduvilath T; Stapleton F
    Optom Vis Sci; 2009 Jul; 86(7):857-67. PubMed ID: 19525883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
    Jiao J
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Corneal sensitivity and aqueous tear production in dogs undergoing evisceration with intraocular prosthesis placement.
    Blocker T; Hoffman A; Schaeffer DJ; Wallin JA
    Vet Ophthalmol; 2007; 10(3):147-54. PubMed ID: 17445075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Capacity and tolerance of a new device for ocular drug delivery.
    Pijls RT; Cruysberg LP; Nuijts RM; Dias AA; Koole LH
    Int J Pharm; 2007 Aug; 341(1-2):152-61. PubMed ID: 17524579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ocular effects of topical 0.03% bimatoprost solution in normotensive feline eyes.
    Regnier A; Lemagne C; Ponchet A; Cazalot G; Concordet D; Gelatt KN
    Vet Ophthalmol; 2006; 9(1):39-43. PubMed ID: 16409244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of risk factors, management, and outcome associated with rectal tears in horses: 99 cases (1985-2006).
    Claes A; Ball BA; Brown JA; Kass PH
    J Am Vet Med Assoc; 2008 Nov; 233(10):1605-9. PubMed ID: 19014297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Symptomatic dry eye treatment with autologous platelet-rich plasma.
    Alio JL; Colecha JR; Pastor S; Rodriguez A; Artola A
    Ophthalmic Res; 2007; 39(3):124-9. PubMed ID: 17374962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.